News & Perspective

Mar 21, 2019

Mar 21, 2019

News Scan for Mar 21, 2019

CDC updates Zika guidelines
Investments to end TB
Foodborne disease in soldiers
Yellow fever vaccine in Sudan
Cryptosporidium in groundwater

Mar 20, 2019

Mar 20, 2019

Stewardship / Resistance Scan for Mar 20, 2019

Gloves, gowns, and MDROs
WHO drug-resistant TB guidelines
Antibiotic development partnership
Lung disease bacteria in tap water

Mar 19, 2019

Mar 19, 2019
Using stethoscope to assess lungs

Report highlights success, challenges in fight to end TB

Though incidence is down, treatment success for resistant strains is low.

Mar 14, 2019

Mar 14, 2019
Mycobacterium tuberculosis bacteria

Trial data support shorter drug-resistant TB regimen

Short-course therapy led to a favorable outcome in 79% of patients, compared with 80% in long-course patients.

Feb 08, 2019

Feb 08, 2019

Stewardship / Resistance Scan for Feb 08, 2019

Inadequate TB drug-susceptibility testing
New UK guidance on antibiotics for acute cough

Dec 03, 2018

Dec 03, 2018

News Scan for Dec 03, 2018

Severe Zika thrombocytopenia
Polio outbreak over in Syria
UK vaccine center, more CEPI funds
TB funding climbs

Oct 19, 2018

Oct 19, 2018

Stewardship / Resistance Scan for Oct 19, 2018

Undetected MDR-TB in South Africa
Carbapenem prescribing algorithm

Sep 26, 2018

Sep 26, 2018

News Scan for Sep 26, 2018

Expanded retail info in food recalls
Flu transmission and humidity
Novel pertussis vaccine
Global TB commitment

Sep 18, 2018

Sep 18, 2018
Mycobacterium tuberculosis bacteria

WHO report warns efforts to end TB are falling short

TB remains high in many low- and middle-income nations, and about 558,000 people in 2017 developed rifampicin-resistant TB.

Sep 07, 2018

Sep 07, 2018
Capsules and syringe

Study provides data behind new MDR-TB guidance

Newer and repurposed drugs produced better results and fewer deaths than older treatments did.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»